Page last updated: 2024-11-07

dehydroepiandrosterone and Glioblastoma

dehydroepiandrosterone has been researched along with Glioblastoma in 2 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kim, SJ3
Park, SJ3
Park, J3
Cho, HJ3
Shim, JK3
Seon, J3
Choi, RJ3
Yoon, SJ3
Moon, JH3
Kim, EH3
Seo, EK3
Kim, SH3
Kim, HS3
Teo, WY3
Chang, JH3
Yook, JI3
Kang, SG3
Yang, WB1
Chuang, JY1
Ko, CY1
Chang, WC1
Hsu, TI1

Other Studies

2 other studies available for dehydroepiandrosterone and Glioblastoma

ArticleYear
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
    Journal of neuro-oncology, 2022, Volume: 160, Issue:3

    Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G

2022
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
    Journal of neuro-oncology, 2022, Volume: 160, Issue:3

    Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G

2022
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
    Journal of neuro-oncology, 2022, Volume: 160, Issue:3

    Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G

2022
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
    Journal of neuro-oncology, 2022, Volume: 160, Issue:3

    Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G

2022
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
    Journal of neuro-oncology, 2022, Volume: 160, Issue:3

    Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G

2022
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
    Journal of neuro-oncology, 2022, Volume: 160, Issue:3

    Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G

2022
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
    Journal of neuro-oncology, 2022, Volume: 160, Issue:3

    Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G

2022
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
    Journal of neuro-oncology, 2022, Volume: 160, Issue:3

    Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G

2022
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
    Journal of neuro-oncology, 2022, Volume: 160, Issue:3

    Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Dehydroepiandrosterone; Glioblastoma; G

2022
Dehydroepiandrosterone Induces Temozolomide Resistance Through Modulating Phosphorylation and Acetylation of Sp1 in Glioblastoma.
    Molecular neurobiology, 2019, Volume: 56, Issue:4

    Topics: Acetylation; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Dehydroepiandrosterone; DNA Damage; Dr

2019